The Effect of Antioxidants on Skin Blood Flow-BH4

计划入组 16 人 · 首次发布于 2018 年 9 月 21 日

Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment

计划入组 12 人 · 首次发布于 2015 年 8 月 21 日

Novel Approaches for Improving Vascular Function in Veterans With HFpEF

计划入组 90 人 · 首次发布于 2024 年 3 月 15 日

Sapropterin(Javygtor, Kuvan, Sapropterin Dipharma)

C₉H₁₅N₅O₃ · Rx

bH1

BHH-0492

NATURECEUTICALS SDN. BHD.

Malaysia

BHR Pharma, LLC

United States

CRYOCORD SDN. BHD.

Malaysia

PTC Therapeutics' Sephience (sepiapterin) Data Reinforce Broad PKU Benefits, Including Diet Liberalization and Sustained Metabolic Control

FDA Accepts PTC Therapeutics' NDA for Sepiapterin to Treat PKU

PTC Therapeutics Secures Global Approvals for Sephience in PKU Treatment Across Canada and Japan